UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): June 27, 2013

 

 

 LIFE CARE MEDICAL DEVICES LIMITED

 
 

(Exact Name of Registrant as Specified in Charter) 

 

 

Nevada 000-54632 98-0576696

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

     
880 Third Avenue, Suite 905, New York, NY 10022
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (917) 860-4514

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

 On June 27, 2013, Life Care Medical Devices Limited (the “Company”) entered into a Letter of Agreement with MED Surgical, providing MED Surgical with exclusive distribution rights for the Company’s Keyhole Cup® Laparoscopic Access Device. The agreement’s initial term runs until June 27, 2014, subject to extension by either party. The foregoing summary of the terms of the Letter of Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Letter of Agreement, a copy of which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  LIFE CARE MEDICAL DEVICES LIMITED
   
   
Date:  July 3, 2013 /s/ Glenn Foley
  Name:    Glenn Foley
  Title:      Chief Executive Officer